CHD is present in 3–12 in 1000 births, but the incidence may be as high as 5% when strictly including all cardiovascular malformations such as bicuspid aortic valve.Reference Hoffman 1 – Reference Stoll, Dott, Alembik and Roth 5 The genetic basis of CHD is well establishedReference Pierpont, Basson and Benson 4 – for instance, the Baltimore–Washington Infant Study in 1989 reported chromosomal abnormalities in nearly 13% of infants with CHD.Reference Ferencz, Neill and Boughman 6 More recent studies have observed that 20–30% of infants with CHD have a recognised genetic syndrome or significant non-cardiovascular anomaly.Reference Stoll, Dott, Alembik and Roth 5 , Reference Eskedal, Hagemo and Eskild 7 , Reference Fuller, Nord and Gerdes 8 Even among patients with isolated CHD, there is evidence for heritability and increased familial recurrence risk that may be particularly important for certain classes of CHD such as heterotaxy, left ventricular outflow tract obstructive lesions, and atrioventricular septal defects.Reference Oyen, Poulsen and Boyd 9 , Reference Hinton, Martin and Tabangin 10 In a minority of cases, gene mutations in NKX2-5, GATA4, and NOTCH1 have been observed in families demonstrating Mendelian inheritance.Reference Schott, Benson and Basson 11 – Reference Garg, Muth and Ransom 13 With the advancement of genetic technologies including DNA microarray and high-throughput sequencing platforms detection of genetic causes of CHD continues to grow rapidly.Reference Fahed, Gelb, Seidman and Seidman 14 – Reference Glessner, Bick and Ito 16 It is critical that clinicians recognise the clinical relevance of a genetic diagnosis in order to improve outcomes, not only for syndromic patients but also for all CHD patients with informative genotypes. The peri-operative time period exposes patients to risk for significant complications that may have both immediate and long-term repercussions, including quality of life or neurocognitive outcomes.Reference Marino, Lipkin and Newburger 17 , Reference Marino, Tomlinson and Wernovsky 18 The aims of this review were to present the spectrum of peri-operative risks for patients with a genetic syndrome and CHD, comprehensively organise observations about the outcomes of patients with genetic syndromes, and synthesise our current understanding of the genetic basis of CHD as a tool for informing the peri-operative management of these patients.
Advances in cardiac surgery, catheterisation, and intensive care have significantly reduced mortality associated with CHD,Reference Gilboa, Salemi, Nembhard, Fixler and Correa 19 shifting the focus towards minimising short- and long-term morbidity. There are well-recognised peri-operative risks for all children undergoing cardiac surgery, including but not limited to myocardial dysfunction, arrhythmias, respiratory failure, infection, bleeding, thrombosis, kidney injury, and neurological injury.Reference Bronicki and Chang 20 However, the CHD sub-population with syndromic disease often has important non-cardiovascular and functional – that is, non-structural – cardiovascular abnormalities that significantly modify these routine peri-operative risks or present additional risks that contribute to morbidity and mortality. It is certain that the cardiac surgeon, anaesthesiologist, intensivist, and cardiologist will frequently encounter children with a syndromic disorder. To our knowledge, the specific peri-operative risks that exist for patients with CHD and genetic syndromes have not previously been consolidated into a single source.
Many large studies have enrolled syndromic patients to broadly evaluate the impact of a syndromic diagnosis on surgical outcomes
Widely inclusive studies, which have analysed all types of paediatric cardiac surgical operations together, have observed that a syndromic diagnosis may not impact early operative mortality but does predispose to post-operative complications contributing to prolonged hospital length of stay.Reference Simsic, Coleman, Maher, Cuadrado and Kirshbom 21 – Reference Kagen, Lautenbach and Bilker 24 However, batching all types of CHD in this manner provides limited insight into risk factors, as both the genetic basis and the risk profiles of different cardiac lesions vary. Sub-classes of cardiac lesions that have been studied specifically include critical left ventricular outflow tract obstructive lesions and conotruncal defects. Detailed information about these studies, including study types, enrollment numbers, cardiac and genetic diagnoses, and early mortality and morbidity outcomes, is provided in Supplementary Table S1.
Patel et alReference Patel, Hickey and Mavroudis 25 extensively reviewed early post-operative outcomes data for hypoplastic left heart syndrome/critical left ventricular outflow tract obstruction from both the Society of Thoracic Surgeons – ~1200 Norwood operations from 2002 to 2006 – and the Congenital Heart Surgeons’ Society ~700 stage 1 palliations from 1994 to 2001 – databases. In the Society of Thoracic Surgeons database, 15% of patients were documented to have a “genetic and/or significant non-cardiovascular abnormality”, which was associated with increased in-hospital mortality (26.7 versus 19.8%). Similarly, in the Congenital Heart Surgeons’ Society database, 8% had a “non-cardiac congenital abnormality or syndrome”, which was associated with increased early risk of mortality. These mortality data are consistent with two other single-centre reports (together 310 patients)Reference Stasik, Gelehrter and Goldberg 26 , Reference Jacobs, O’Brien and Chai 27 and with data from the Pediatric Heart Network’s Single Ventricle Reconstruction trial including 549 patients undergoing Norwood operations.Reference Tabbutt, Ghanayem and Ravishankar 28 This evidence is countered only by a single series of 158 patients who underwent Norwood operation.Reference Gaynor, Mahle and Cohen 29 The Society of Thoracic Surgeons data demonstrate that in-hospital mortality was not increased after stage 2 (~700 operations) or stage 3 palliations (~550 operations), recognising that stage 1 mortality may limit interpretation.Reference Patel, Hickey and Mavroudis 25 Increased morbidity was observed after all stages of palliation.Reference Patel, Hickey and Mavroudis 25 , Reference Hornik, He and Jacobs 30
Michielon et alReference Michielon, Marino and Oricchio 31 provided important perspective in a cohort of nearly 800 patients with conotruncal defects – tetralogy of Fallot with or without pulmonary atresia, double-outlet right ventricle, truncus arteriosus, or interrupted aortic arch – undergoing biventricular repair from 1992 to 2007. Uniquely, nearly every patient in the cohort (96%) underwent clinical evaluation by a geneticist and prospective molecular screening (93%) for 22q11 deletion or aneuploidy. A genetic diagnosis was established in ~27% of these patients and was associated with increased hospital mortality (17 versus 7%) and prolonged duration of intensive care. These findings were consistent with previous observations in 266 patients with tetralogy of Fallot with normal pulmonary artery anatomy.Reference Michielon, Marino and Formigari 32 Similarly, a cohort of 350 patients with conotruncal defects undergoing primary or staged repair trended towards increased early mortality.Reference Anaclerio, Di Ciommo and Michielon 33
Taken together, the presence of a genetic syndrome may negatively impact early post-operative survival, particularly in the context of more complex cardiac operations such as the Norwood operation. It is particularly clear that post-operative morbidity risk is consistently elevated across the spectrum of cardiac lesions. These are very important observations, but are based on data from heterogeneous groups of genetic syndromes, which limit generalisability to specific syndromes. Moreover, batching patients with non-cardiovascular malformations lacking a defined genetic syndrome together with those who have a defined genetic syndrome creates challenges. In order to understand the risk factors and clinically intervene to improve outcomes, more precise data are required. To this end, the remainder of this article focuses on outcomes and risk factors for specific syndromic CHD populations.
The presence of a specific genetic syndrome impacts early peri-operative outcomes, and genetic syndromes often present with specific features posing significant peri-operative risks
Down syndrome
Down syndrome is present in at least one in 1000 live births and is caused by trisomy of chromosome 21 due to true aneuploidy, unbalanced translocation, or mosaicism.Reference Bull 34 , Reference Cocchi, Gualdi and Bower 35 Approximately 40–50% of patients with Down syndrome present with CHD, most frequently atrioventricular septal defect, followed by ventricular septal defect, atrial septal defect, patent ductus arteriosus, and tetralogy of Fallot.Reference Bull 34 , Reference Freeman, Taft and Dooley 36
Survival after cardiac surgery is generally favourable, as summarised in Table 1, with more detailed information in Supplementary Table S2; three large contemporary database reviews – encompassing a spectrum of cardiac operations and cumulatively including nearly 7000 patients with Down syndrome – demonstrated that in-hospital mortality risk decreased (Healthcare Cost and Utilization Project Kids’ Inpatient Database)Reference Evans, Dharmar, Meierhenry, Marcin and Raff 37 , Reference Seifert, Howard, Silber and Jobes 38 or was not different (Society of Thoracic Surgeons database)Reference Fudge, Li and Jaggers 39 when compared with children without Down syndrome. Cardiac lesions studied specifically in Down syndrome are atrioventricular septal defects, conotruncal defects (primarily tetralogy of Fallot), and single ventricle lesions. Poor outcomes after repair of atrioventricular septal defects were reported in early surgical eras,Reference Morris, Magilke and Reller 40 , Reference Reller and Morris 41 but recent evidence indicates that children with Down syndrome undergoing biventricular repair for complete atrioventricular septal defect have betterReference Evans, Dharmar, Meierhenry, Marcin and Raff 37 , Reference St Louis, Jodhka and Jacobs 42 or similar early mortality ratesReference Formigari, Di Donato and Gargiulo 43 – Reference Lange, Guenther, Busch, Hess and Schreiber 46 compared with patients without Down syndrome. Re-operation rates may be lower in Down syndrome, likely related to less complex atrioventricular valve and outflow tract anatomy.Reference St Louis, Jodhka and Jacobs 42 – Reference Al-Hay, MacNeill, Yacoub, Shore and Shinebourne 44 , Reference Lange, Guenther, Busch, Hess and Schreiber 46 Increased risk for post-operative complete heart block is reported after ventricular septal defect repairReference Fudge, Li and Jaggers 39 , Reference Tucker, Pyles, Bass and Moller 47 but not after atrioventricular septal defect repair.Reference St Louis, Jodhka and Jacobs 42 , Reference Desai, Branco and Comitis 48
Table 1 Summary of post-operative mortality and hospital length of stay outcomes among four frequently encountered genetic syndromes.
![](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20170718130426-37082-mediumThumb-S1047951115001389_tab1.jpg?pub-status=live)
AVSD=atrioventricular septal defect; CoA=coarctation of the aorta; IAA=interrupted aortic arch; LOS=length of stay (in-hospital); PA-VSD=pulmonary atresia with ventricular septal defect; PTA=persistent truncus arteriosus; SV=single ventricle; TAPVR=total anomalous pulmonary venous return; TOF=tetralogy of Fallot; and VSD=ventricular septal defect
Classification of risk for poor early post-operative outcomes relative to patients without the syndromic diagnosis (high: studies reviewed only demonstrating increased mortality or LOS, medium: studies demonstrating increased or no difference in mortality or LOS, low: studies demonstrating no difference in mortality or LOS)
* Some studies reported decreased mortality
** Studies reported increased mortality, decreased mortality, and no difference in mortality
Similar to complete atrioventricular septal defect repair, Down syndrome does not significantly impact early mortality after surgery for tetralogy of FallotReference Michielon, Marino and Formigari 32 , Reference Evans, Dharmar, Meierhenry, Marcin and Raff 37 , Reference Fudge, Li and Jaggers 39 , Reference Reller and Morris 41 , Reference Mulder, Pyles, Stolfi, Pickoff and Moller 49 or conotruncal defects collectively (predominantly tetralogy of Fallot).Reference Michielon, Marino and Oricchio 31 , Reference Anaclerio, Di Ciommo and Michielon 33 In contrast, Down syndrome may significantly worsen outcomes for single ventricle lesions. Review of the Kids’ Inpatient Database found that early mortality was increased both after systemic-to-pulmonary shunt placement and after stage 2 palliation.Reference Evans, Dharmar, Meierhenry, Marcin and Raff 37 Review of the Society of Thoracic Surgeons database also demonstrated increased hospital mortality for all stages of single ventricle palliation.Reference Fudge, Li and Jaggers 39 Increased mortality (35%) after stage 3 palliation was observed in the Pediatric Cardiac Care Consortium databaseReference Gupta-Malhotra, Larson, Rosengart, Guo and Moller 50 but was not corroborated by the Kids’ Inpatient Database or a smaller single-centre series.Reference Evans, Dharmar, Meierhenry, Marcin and Raff 37 , Reference Furukawa, Park and Yoshikawa 51 The reasons for poor outcomes after single ventricle palliations in these patients are undefined but likely related to predisposition for pulmonary hypertension, which may also contribute to prolonged hospitalisation after stage 2 and stage 3 palliations.Reference Fudge, Li and Jaggers 39 , Reference Furukawa, Park and Yoshikawa 51
Many features of Down syndrome impact peri-operative morbidity. Pulmonary and pulmonary vascular co-morbidities feature prominently (Table 2 and Supplementary Table S3). Congenital respiratory tract anomalies may be present at multiple levels and include macroglossia/glossoptosis, adenotonsillar hypertrophy, sub-glottic stenosis, laryngomalacia, tracheal stenosis, complete tracheal rings, and tracheobronchomalacia. Hypotonia can exacerbate anatomical narrowing. Patients are at risk for pulmonary hypertension due to chronic hypoventilation related to airway obstruction and sleep apnoea as well as intrinsic risk for pulmonary vascular disease.Reference Levine and Simpser 52 – Reference Stebbens, Dennis, Samuels, Croft and Southall 54 Craniofacial and upper airway anomalies can complicate peri-operative airway management and/or performance of trans-oesophageal echocardiography.Reference Shott 55 – Reference Hilberath, Oakes and Shernan 57 Pulmonary abnormalities include pulmonary hypoplasia, interstitial lung disease secondary to chronic aspiration or infection, tracheal bronchus predisposing to recurrent right upper lobe collapse or pneumonia, sub-pleural cysts predisposing to pneumothorax, and lymphatic abnormalities including pulmonary lymphangiectasia.Reference Cooney and Thurlbeck 58 – Reference Ochiai, Hikino and Nakayama 63 These airway co-morbidities manifest clinically as increased risk for post-operative respiratory complications,Reference Fudge, Li and Jaggers 39 , Reference Desai, Branco and Comitis 48 , Reference Ip, Chiu and Cheung 64 prolonged mechanical ventilation,Reference Furukawa, Park and Yoshikawa 51 , Reference Ip, Chiu and Cheung 64 , Reference Morray, Mac Gillivray and Duker 65 pneumothorax,Reference Desai, Branco and Comitis 48 chylothorax,Reference Doell, Bernet and Molinari 22 , Reference Fudge, Li and Jaggers 39 chylopericardium,Reference Campbell, Benson, Williams and Adatia 66 and failed extubation.Reference Harrison, Cox and Davis 67 These observations mandate vigilant assessment and treatment of the pulmonary status in the post-operative period, which may be optimised by pre-operative consultation and testing, particularly in high-risk patients – for example, single ventricle lesions.
Table 2 Classes of risks and suggested peri-operative precautions/actions for specific syndromes.
![](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20170718130426-36366-mediumThumb-S1047951115001389_tab2.jpg?pub-status=live)
AGS=Alagille syndrome; AV=atrioventricular; BP=blood pressure; CPB=cardiopulmonary bypass; DS=Down syndrome; EEG=electroencephalogram; EVC=Ellis–van Creveld; HTX=heterotaxy syndrome; LDS=Loeys–Dietz syndrome; LQT=prolonged QT interval; MFS=Marfan syndrome; NS=Noonan syndrome; PVR=pulmonary vascular resistance; SND=sinus node dysfunction; TS=Turner syndrome; and WS=Williams syndrome
Dysfunction of B- and T-lymphocytes and neutrophils may predispose to infections and exacerbate the inflammatory response to cardiopulmonary bypass.Reference Doell, Bernet and Molinari 22 , Reference Fudge, Li and Jaggers 39 , Reference Desai, Branco and Comitis 48 , Reference Furukawa, Park and Yoshikawa 51 , Reference Kusters, Verstegen, Gemen and de Vries 68 – Reference Roussot, Lawrenson, Hewitson, Smart and De Decker 71 Congenital hypothyroidism occurs in ~1%, and thyroid screening at regular intervals, including at ages 6 and 12 months, is indicated because an additional 4–18% develop hypothyroidism.Reference Bull 34 , Reference Murphy, Philip and Macken 72 , Reference Gibson, Newton and Selby 73 Pre-operative thyroid screening is indicated so that hypothyroidism can be treated pre-operatively. As thyroid levels decrease with cardiopulmonary bypass surgery and impact myocardial function and cardiovascular stability,Reference Talwar, Khadgawat and Sandeep 74 , Reference Plumpton, Anderson and Beca 75 intra-operative and post-operative parenteral therapy may be indicated. The risk for atlantoaxial instability calls for appropriate peri-operative precautionary measures to avoid neurological injury, especially in mid-to-late childhood.Reference Bull 34 , Reference Davidson 76 Increased risk for seizures – ~8% in the general Down syndrome population – should also be considered.Reference Goldberg-Stern, Strawsburg and Patterson 77 Taken together, Down syndrome presents significant co-morbidities that can impact peri-operative outcomes. Fortunately, mortality outcomes have improved over time for the most-frequent lesions, but non-cardiovascular abnormalities continue to contribute to post-operative morbidity outcomes and require clinical vigilance and future research.
22q11 deletion syndrome
Microdeletion of 22q11.2 causes several disorders with overlapping clinical phenotypes including DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face syndrome, and is present in approximately one in 5000 live births.Reference Tezenas Du Montcel, Mendizabai, Ayme, Levy and Philip 78 , Reference Goodship, Cross, LiLing and Wren 79 Suggestive features include long narrow face and small protuberant ears with thick and crumpled helices.Reference Bassett, McDonald-McGinn and Devriendt 80 CHD is present in at least 75%.Reference Ryan, Goodship and Wilson 81 The typical cardiac lesions are conotruncal defects and abnormalities of the aortic arch and brachiocephalic arteries, including type B interrupted aortic arch, truncus arteriosus, tetralogy of Fallot, pulmonary atresia with ventricular septal defect, isolated ventricular septal defect, and abnormal aortic arch sidedness and/or branching.Reference Goldmuntz, Clark and Mitchell 82 – Reference McElhinney, Driscoll and Levin 84
Peri-operative outcomes are summarised in Table 1 with more detailed information in Supplementary Table S4. Early reports observed very high operative mortality in neonates with DiGeorge syndrome.Reference Marmon, Balsara, Chen and Dunn 85 Although increased hospital mortality was also observed in a more contemporary series of patients with conotruncal defects,Reference Anaclerio, Di Ciommo and Michielon 33 there is strong evidence that 22q11 deletion no longer results in early mortality for the vast majority of cardiac lesions;Reference Michielon, Marino and Oricchio 31 , Reference Michielon, Marino and Formigari 32 , Reference Mercer-Rosa, Pinto, Yang, Tanel and Goldmuntz 86 – Reference McDonald, Dodgen and Goyal 88 however, substantial post-operative morbidity persists including slow recovery and increased frequency of cardiac events such as the need for re-operation.Reference Michielon, Marino and Oricchio 31 , Reference Michielon, Marino and Formigari 32 , Reference Mercer-Rosa, Pinto, Yang, Tanel and Goldmuntz 86 , Reference O’Byrne, Yang and Mercer-Rosa 87 Notably, patients with pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries have consistently demonstrated increased early mortality in the setting of 22q11 deletion.Reference Reddy, McElhinney and Amin 89 – Reference Carotti, Albanese and Filippelli 93 In addition, early operative mortality after Norwood stage 1 operation was observed in two of five patients in the Congenital Heart Surgeons’ Society database from 1994 to 2001, supporting the concept that genetic syndromes continue to impact high-risk operations.Reference Patel, Hickey and Mavroudis 25
Congenital malformations including cleft palate, sub-mucous clefts, retrognathia, Pierre Robin sequence, congenital laryngeal web, and vascular ring may complicate airway management.Reference Ryan, Goodship and Wilson 81 , Reference Yotsui-Tsuchimochi, Higa, Matsunaga, Nitahara and Shono 94 , Reference McElhinney, Jacobs, McDonald-McGinn, Zackai and Goldmuntz 95 Bronchomalacia and bronchospasm have been observed in patients with 22q11 deletion and pulmonary atresia with ventricular septal defect, which may be related to compression by aortopulmonary collateral vessels.Reference Yamagishi, Maeda and Higuchi 96 , Reference Ackerman, Wylam and Feldt 97 Although prolonged mechanical ventilation was not observed after unifocalisation of the major aortopulmonary collateral arteries,Reference Asija, Hanley and Roth 98 increased post-operative respiratory complications including prolonged intubation and post-extubation stridor have been observed.Reference Ziolkowska, Kawalec and Turska-Kmiec 99
Thymic aplasia occurs rarely (<1% of cases) and is associated with severe immune deficiency. More commonly, thymic hypoplasia causes mild-to-moderate immune deficiency. Complete pre-operative immunological evaluation and blood product precautions – cytomegalovirus-negative and irradiated blood products – are indicated for all cases to prevent iatrogenic infection and graft versus host disease.Reference Bassett, McDonald-McGinn and Devriendt 80 , Reference Marmon, Balsara, Chen and Dunn 85 , Reference Jatana, Gillis, Webster and Ades 100 Low T-lymphocyte counts are present in 75–80% of patients with 22q11 deletion.Reference Kobrynski and Sullivan 101 B-lymphocyte dysfunction with immunoglobulin deficiency also may have clinical significance.Reference Patel, Akhter and Kobrynski 102 , Reference Smith, Driscoll and Emanuel 103 Frequent infectious complications including fungal infections have been reportedReference Barker, O’Brien and Welke 23 , Reference Marmon, Balsara, Chen and Dunn 85 , Reference McDonald, Dodgen and Goyal 88 , Reference Carotti, Marino and Di Donato 91 , Reference Ziolkowska, Kawalec and Turska-Kmiec 99 but not uniformly.Reference Mercer-Rosa, Pinto, Yang, Tanel and Goldmuntz 86 , Reference O’Byrne, Yang and Mercer-Rosa 87 , Reference Mahle, Crisalli and Coleman 90 It has been suggested that prophylaxis with broad-spectrum antibiotics including antifungal agents may be indicated.Reference Carotti, Digilio and Piacentini 104 Developmental hypoplasia of the parathyroid glands results in hypocalcaemia in 40–80% of patients and is often accompanied by hypomagnesaemia.Reference Cheung, George and Costain 105 Close peri-operative electrolyte monitoring is necessary to preserve cardiac function, avoid dysrhythmia, and prevent secondary seizures. Peri-operative seizures are linked to worse neurodevelopmental outcomes in 22q11 deletion.Reference Cheung, George and Andrade 106 Annual assessment of thyroid function is recommended because hypothyroidism is present in 20–30% of patients; a routine pre-operative thyroid screening approach similar to Down syndrome may be reasonable.Reference Bassett, McDonald-McGinn and Devriendt 80 , Reference Cheung, George and Costain 105 , Reference Stagi, Lapi and Gambineri 107
Interestingly, the gene encoding glycoprotein Ib (GP1BB), which is responsible for autosomal-recessive Bernard–Soulier disease, is located within the 22q11 region. Patients with 22q11 deletion, and thus hemizygous deletion of GP1BB, may have abnormally large platelets and thrombocytopaenia (macrothrombocytopaenia).Reference Naqvi, Davidson and Wong 108 , Reference Latger-Cannard, Bensoussan and Gregoire 109 Platelet dysfunction has been described previously.Reference Liang, Morel-Kopp and Curtin 110 , Reference Kato, Kosaka and Kimura 111 Post-operative bleeding accounted for a significant proportion of post-operative deaths in patients with pulmonary atresia with ventricular septal defect.Reference Mahle, Crisalli and Coleman 90 , Reference Carotti, Albanese and Filippelli 93 A complete haematological workup may be indicated before operations requiring small vessel anastomoses – for example, unifocalisation – and unexplained severe post-operative bleeding should trigger concern for Bernard–Soulier disease due to mutation of the non-deleted GP1BB allele.Reference Nakagawa, Okuno, Okamoto, Fujino and Kato 112 Renal and urinary tract abnormalities are present in 30–40% of patients, including renal agenesis, multi-cystic dysplastic kidneys, hydronephrosis, and vesicoureteral reflux.Reference Ryan, Goodship and Wilson 81 , Reference Stewart, Irons, Cowan and Bianchi 113 Increased need for post-operative dialysis has been observed.Reference McDonald, Dodgen and Goyal 88 Autonomic dysfunction may in some cases explain post-operative hypotension refractory to usual therapy.Reference Shashi, Berry and Hines 114 Taken together, the developmental abnormalities associated with 22q11 deletion likely contribute to mortality after complex operations and morbidity across the spectrum of CHD surgery. Improvements in anticipatory management of common abnormalities – for example, immune dysfunction and hypocalcaemia – will continue to improve outcomes. Abnormalities that are less frequently recognised – for example,. haematological dysfunction – should be anticipated and acted upon when deviation from expected recovery is encountered.
Heterotaxy syndrome
Heterotaxy syndrome, a disorder of laterality characterised by abnormal thoracoabdominal situs, is frequently associated with CHD and is present in at least one in 10,000 live births.Reference Lin, Ticho, Houde, Westgate and Holmes 115 Mutations in genes such as DNAH5, ZIC3, CFC1, NODAL, ACVR2B, DNAI1, and LEFTY2, many of which are components of the Nodal signal transduction pathway, have been identified;Reference Sutherland and Ware 116 familial recurrence is more frequently observed compared with other cardiac lesions.Reference Oyen, Poulsen and Boyd 9 CHD is often complex, including complete atrioventricular canal defect, anomalous pulmonary and systemic venous return, and pulmonary outflow tract obstruction. Heterotaxy can be sub-classified as right atrial isomerism versus left atrial isomerism as determined by atrial appendage and bronchopulmonary anatomy.Reference Jacobs, Anderson and Weinberg 117 In general terms, right atrial isomerism typically has more severe CHD, often requires single ventricle palliation, and has worse survival in childhood.Reference Lim, McCrindle and Smallhorn 118 – Reference Freedom, Jaeggi, Lim and Anderson 120 In right atrial isomerism, abnormal morphology and function of the sinoatrial node and the atrioventricular conduction system predispose to both tachyarrhythmia and bradyarrhythmiaReference Gilljam, McCrindle, Smallhorn, Williams and Freedom 121 – Reference Kim, Kim, Lim and Lee 124 – for instance, supra-ventricular tachycardia has been observed in up to 25% of cases, including re-entrant mechanisms mediated by twin atrioventricular nodes.Reference Wren, Macartney and Deanfield 125 – Reference Anagnostopoulos, Pearl and Octave 127 Atrioventricular block and sinus node dysfunction are more frequently observed in left atrial isomerism.Reference Wren, Macartney and Deanfield 125 , Reference Anagnostopoulos, Pearl and Octave 127 In addition to arrhythmia concerns, non-compaction cardiomyopathy is described and may contribute to unexpected ventricular dysfunction.Reference Wessels, De Graaf and Cohen-Overbeek 128
Peri-operative outcomes in heterotaxy are summarised in Table 1 and Supplementary Table S5. The complexities of both cardiovascular and non-cardiovascular abnormalities likely contribute to poor outcomes.Reference Freedom, Jaeggi, Lim and Anderson 120 Increased mortality following any cardiac surgery has been observed in the Society of Thoracic Surgeons’ database.Reference Jacobs, Pasquali and Morales 129 , Reference Swisher, Jonas and Tian 130 Mortality after initial single ventricle palliation is reported to range from 10 to 23%.Reference Gilljam, McCrindle, Smallhorn, Williams and Freedom 121 , Reference Jacobs, Pasquali and Morales 129 , Reference Ota, Fujimoto and Murata 131 , Reference Hashmi, Abu-Sulaiman and McCrindle 132 In the setting of total anomalous pulmonary venous return, poor outcomes may be related to hypoplastic pulmonary veins and increased pulmonary vascular reactivity.Reference Ota, Fujimoto and Murata 131 – Reference Jenkins, Sanders and Orav 133 Despite these challenges, there was similar survival between heterotaxy and non-heterotaxy patients undergoing primary repair for total anomalous pulmonary venous return but increased need for pulmonary vein re-operation.Reference Morales, Braud and Booth 134 Mortality rates after stage 3 palliation ranged widely from as high as 19–43%Reference Stamm, Friehs and Duebener 123 , Reference Bartz, Driscoll and Dearani 135 , Reference Humes, Feldt and Porter 136 to as low as 3–4% in recent studies.Reference Stamm, Friehs and Duebener 123 , Reference Kim, Kim, Lim and Lee 124 , Reference Jacobs, Pasquali and Morales 129 Complex anatomy can potentially complicate cardiac transplantation but did not impact early (or late) graft survival;Reference Larsen, Eguchi and Mulla 137 however, early mortality was recently reported in two of five patients undergoing cardiac transplantation.Reference Jacobs, Asante-Korang and O’Brien 138 Overall, there is strong evidence that heterotaxy confers significant peri-operative mortality risk.
Post-operative respiratory morbidity was frequently observed.Reference Swisher, Jonas and Tian 130 Up to 40% of patients with heterotaxy and CHD have dysfunctional airway cilia similar to primary ciliary dyskinaesia.Reference Nakhleh, Francis and Giese 139 Indeed, ciliopathy is a suspected developmental mechanism for cardiovascular and non-cardiovascular malformations.Reference Sutherland and Ware 116 Respiratory ciliary dysfunction, diagnosed by nasal nitric oxide levels or nasal video microscopy, has been associated with post-operative respiratory complications, including failed extubation, respiratory failure, respiratory infection, stridor, pleural effusion, atelectasis, pneumothorax, or pulmonary oedema, as well as with the need for tracheostomy.Reference Harden, Tian and Giese 140 It has been suggested that beta-agonist therapy may be effective by improving ciliary motility.Reference Harden, Tian and Giese 140 , Reference Shiima-Kinoshita, Min, Hanafusa, Mori and Nakahari 141
Splenic abnormalities including asplenia (often left atrial isomerism) polysplenia (often right atrial isomerism) or the presence of accessory splenule are frequently observed.Reference Anderson, Devine, Anderson, Debich and Zuberbuhler 142 Asplenia clearly increases risk of bacterial infections in children.Reference Waldman, Rosenthal, Smith, Shurin and Nadas 143 Splenic function in the setting of polysplenia may also be impaired and should be evaluated using scintigraphy.Reference de Porto, Lammers and Bennink 144 Sepsis was the cause of early post-operative mortality in 13% of deaths in a large heterotaxy population.Reference Serraf, Bensari and Houyel 145 Oropharyngeal malformations including micrognathia, choanal atresia, and cleft lip/palate can contribute to airway management difficulties.Reference Williams and Feng 146 , Reference Ticho, Goldstein and Van Praagh 147 Renal anomalies including renal agenesis, cystic malformation, and horseshoe kidney are also frequently observed.Reference Hashmi, Abu-Sulaiman and McCrindle 132 , Reference Ticho, Goldstein and Van Praagh 147
The surgical outcomes in heterotaxy are improving, but persistent challenges include complex anatomy such as abnormal cardiac position, hypoplastic and anomalous pulmonary veins, and single ventricle morphology, predisposition for arrhythmia, and pulmonary and immunological dysfunction.
Turner syndrome
Turner syndrome occurs in approximately one in 2000 female live births and is caused by complete or partial absence of the X chromosome.Reference Nielsen and Wohlert 148 , Reference Bondy 149 Features include short stature, ovarian dysgenesis, webbed neck, low posterior hairline, and widely spaced nipples.Reference Frias and Davenport 150 There is a high rate of foetal mortality, often in the setting of foetal hydrops.Reference Surerus, Huggon and Allan 151 Those surviving to birth often have cardiovascular malformations including bicuspid aortic valve, coarctation of the aorta, partial anomalous pulmonary venous return, persistent left superior caval vein, and hypoplastic left heart syndrome.Reference Ho, Bakalov and Cooley 152 – Reference Gotzsche, Krag-Olsen, Nielsen, Sorensen and Kristensen 155 Turner syndrome accounts for at least 5% of coarctation of the aorta among girls, which may indicate karyotype screening of all female neonates with coarctation.Reference Wong, Burgess, Cheung and Zacharin 156 There is also significant long-term risk of aortic dilation and dissection that is likely under-recognised.Reference Matura, Ho, Rosing and Bondy 157 , Reference Carlson, Airhart, Lopez and Silberbach 158 Electrocardiographic abnormalities including prolonged QT interval are frequently encountered, but risk of life-threatening arrhythmia has not been established.Reference Bondy, Ceniceros, Van, Bakalov and Rosing 159
Turner syndrome does not appear to increase mortality risk after repair of coarctation of the aorta but has been associated with longer hospitalisation (Table 1 and Supplementary Table S6).Reference Cramer, Bartz, Simpson and Zangwill 160 By comparison, mortality appears to be significantly increased in patients with hypoplastic left heart syndrome – for instance, 9 out of 11 infants with Turner syndrome undergoing Norwood stage 1 operation died by 4 months of age as per the Congenital Heart Surgeons’ Society database.Reference Patel, Hickey and Mavroudis 25 In a retrospective single institution study, 8 out of 10 infants with Turner syndrome undergoing stage 1 palliation for hypoplastic left heart syndrome died before stage 2 operation, and both the survivors were mosaic XO.Reference Reis, Punch, Bove and van de Ven 161 In a more recent series, all four patients with Turner syndrome undergoing stage 1 palliation survived to hospital discharge, but three were reported to have died before stage 3 palliation.Reference Cramer, Bartz, Simpson and Zangwill 160 A precise explanation for these outcomes has not been established thus far, but lymphatic abnormalities may contribute.Reference Reis, Punch, Bove and van de Ven 161 Automatic karyotype screening in girls with hypoplastic left heart syndrome may be indicated because some features develop over time or may be subtle in mosaic cases.
Predisposition to vascular complications were described in earlier case series that reported significant post-operative haemorrhage and risk for aortic rupture, possibly related to increased arterial tissue fragility and peri-operative systemic hypertension.Reference Ravelo, Stephenson and Friedman 162 , Reference Brandt, Heintz, Rose, Ehrenhaft and Clark 163 Fortunately, improvements in surgical technique and intensive care have effectively reduced post-operative bleeding risk. Morphological abnormalities such as elongation of the transverse arch (present in 50% of cases) may impact surgical approach,Reference Ho, Bakalov and Cooley 152 which may lead to longer cross-clamp time during coarctation repair.Reference Cramer, Bartz, Simpson and Zangwill 160 Although unlikely to develop in the early post-operative period, there is established risk for dissection after surgical repair or transcatheter stenting of aortic coarctation.Reference Oza, Siegenthaler and Horvath 164 – Reference Fejzic and van Oort 166 Small case series have provided evidence that balloon angioplasty or stent placement for coarctation is safe and effective in the short term,Reference Kataoka, Ozawa, Inage and Benson 167 , Reference Zanjani, Thanopoulos, Peirone, Alday and Giannakoulas 168 but covered stents may be the best approach in the context of intrinsically abnormal arterial tissue.
The non-cardiovascular abnormalities that potentially impact peri-operative risk and outcomes include the lymphatic, renal, and endocrine systems. Lymphatic dysfunction can present as foetal lymphoedema or pulmonary lymphatic anomalies such as congenital pulmonary lymphangiectasia, which may predispose to post-operative chylothorax.Reference Bellini, Boccardo, Campisi and Bonioli 169 Postnatal peripheral lymphoedema may be a clue to Turner syndrome diagnosis but has no clear clinical impact and usually resolves by 2 years of age without intervention.Reference Bondy 149 Abnormalities of the renal and urinary system are present in 30–40% of patients, including horseshoe kidney in 10%.Reference Bondy 149 Hypothyroidism develops in up to 25% of cases, most commonly autoimmune related, and annual thyroid screening is recommended starting at 4 years of age.Reference Bondy 149 , Reference Gawlik, Gawlik, Januszek-Trzciakowska, Patel and Malecka-Tendera 170 In summary, Turner syndrome most clearly impacts outcomes for hypoplastic left heart syndrome. Further investigation is needed to explain these poor outcomes and develop novel approaches and interventions. Arteriopathy associated with Turner syndrome predisposes to hypertension and aortic complications, such as dissection, mandating acute peri-operative blood pressure management and longitudinal follow-up.
Williams syndrome
Williams syndrome occurs in approximately one in 10,000 live birthsReference Stromme, Bjornstad and Ramstad 171 and is associated with 7q11.23 microdeletion. Haploinsufficiency of the elastin gene (ELN) is responsible for the cardiovascular manifestations. Facial features during infancy include a short upturned nose with a flat nasal bridge, peri-orbital puffiness, and long philtrum and later develop into full lips, wide smile, and coarse appearance. Relative strengths in verbal skills and social personality may belie intellectual disability that is present in most cases.Reference Pober 172 Familial supra-valvar aortic stenosis is associated with ELN mutations and presents with similar cardiovascular features but none of the non-cardiovascular features.
The spectrum of vascular manifestations in Williams syndrome is consistent with generalised arteriopathy. The majority of patients with Williams syndrome have supra-valvar aortic stenosis (45–75%), which may be “hourglass” or “diffuse” type.Reference Collins 173 Severe supra-valvar aortic stenosis is unlikely to regress and can be progressive,Reference Wren, Oslizlok and Bull 174 – Reference Del Pasqua, Rinelli and Toscano 176 but mild stenosis is likely to remain stable.Reference Del Pasqua, Rinelli and Toscano 176 – Reference Collins, Kaplan, Somes and Rome 178 Additional vascular findings include branch pulmonary stenosis, peripheral pulmonary artery stenosis, supra-valvar pulmonary stenosis, and stenosis of the thoracic aorta, as well as bicuspid aortic valve and mitral valve prolapse.Reference Collins 173 The pulmonary arterial lesions often spontaneously improve or resolve over time,Reference Wren, Oslizlok and Bull 174 – Reference Del Pasqua, Rinelli and Toscano 176 , Reference Collins, Kaplan, Somes and Rome 178 but regression also is less likely when severe stenosis is present.Reference Stamm, Friehs and Moran 179 Surgical repair of supra-valvar aortic stenosis in patients with Williams syndrome has good mortality outcomes with no significant difference in long-term survival compared with familial or sporadic supra-valvar aortic stenosis.Reference Deo, Burkhart and Schaff 180 On the other hand, early mortality can be as high as 20% for cases presenting with the combination of severe supra-valvar aortic stenosis and moderate-to-severe pulmonary stenosis.Reference Stamm, Friehs and Moran 179 , Reference Monge, Mainwaring and Sheikh 181
Balloon angioplasty of supra-valvar aortic stenosis has been dispelled due to lack of success.Reference Del Pasqua, Rinelli and Toscano 176 After transcutaneous stent placement for native or residual post-operative aortic coarctation, there is significant risk for developing re-stenosis, characterised by fibrosis and vascular smooth muscle cell proliferation.Reference Apostolopoulou, Kelekis, Laskari, Kaklamanis and Rammos 182 , Reference Mookerjee, Roebuck and Derrick 183 Indeed, patients with stenosis of the thoracic aorta have high re-intervention rates.Reference Collins, Kaplan and Rome 184 The pulmonary arteries are also predisposed to re-stenosis, aneurysm formation, intimal flap formation, dissection, and rupture after catheter-based interventions.Reference Pham, Moller, Hills, Larson and Pyles 185 , Reference Geggel, Gauvreau and Lock 186 These outcomes indicate that arteriopathy may limit the effectiveness and increase risk factors when performing catheter-based interventions for arterial stenoses.
It is critical to recognise the risk of sudden cardiac death in patients with Williams syndrome, particularly during procedural sedation or anaesthesia or coronary angiography.Reference Stamm, Friehs and Moran 179 , Reference Burch, McGowan, Kussman, Powell and DiNardo 187 – Reference Conway, Noonan, Marion and Steeg 190 This risk is highest in those with coronary ostial stenosis or severe biventricular outflow tract obstruction. Among 242 patients with Williams syndrome undergoing 435 cardiac operations or catheter-based interventions, described in the Pediatric Cardiac Care Consortium database, 12 of 15 deaths occurred in the setting of biventricular outflow tract obstruction.Reference Pham, Moller, Hills, Larson and Pyles 185 Coronary ostial stenosis is present in at least 5% of cases and is more common in the “diffuse” type of supra-valvar aortic stenosis or when stenosis of the thoracic aorta is present.Reference Collins, Kaplan, Somes and Rome 178 , Reference Stamm, Li, Ho, Redington and Anderson 191 Potential mechanisms of coronary stenosis include adhesion of aortic valve leaflets, overhanging of the supra-valvar ring, or reactive changes to hypertension. Coronary artery stenosis can develop during childhood in the absence of supra-valvar aortic stenosis,Reference Bonnet, Cormier, Villain, Bonhoeffer and Kachaner 192 , Reference van Pelt, Wilson and Lear 193 and dilation and tortuosity of the coronary arteries are well recognised.Reference Martin and Moseley 194 These observations suggest primary arteriopathic mechanisms. QT interval prolongation is present in up to 15% of cases, which may predispose to ventricular dysrhythmia and also contribute to sudden death risk.Reference Collins, Aziz, Gleason, Kaplan and Shah 195 , Reference Collins, Aziz, Swearingen and Kaplan 196 As coronary stenosis can be sub-clinical, it is critical that patients undergo complete assessment of the coronary arteries when appropriate and that providers be cognizant of the risk factors for sudden death around the time of interventional procedures.
Systemic hypertension develops in up to 50% of individuals, which is secondary to renal artery stenosis in some cases. In most cases, hypertension may rather be due to abnormal vascular function or morphology in the distal arteries, but the precise mechanisms are not well understood.Reference Broder, Reinhardt and Ahern 197 Cerebral artery stenosis causing ischaemic stroke has been observed in children and should be suspected if neurological changes develop.Reference Kaplan, Levinson and Kaplan 198 Selecting target blood pressure ranges around the time of procedures can be complicated by the presence of pre-existing hypertension combined with coronary or cerebral artery stenosis, which requires highly attentive pre-operative and post-operative care.
Owing to a 15–30% prevalence of sub-clinical hypothyroidism, often due to thyroid hypoplasia, thyroid function testing is recommended every 4 years, and pre-operative evaluation should include thyroid function tests and clinical evaluation for symptoms.Reference Stagi, Bindi and Neri 199 – 202 Congenital hypothyroidism due to severe thyroid hypoplasia has also been reported.Reference Stagi, Manoni, Salti, Cecchi and Chiarelli 203 Airway management may be challenging due to facial dysmorphism.Reference Medley, Russo and Tobias 200 Based on a concern for mild myopathy in some patients, there have been recommendations to avoid the use of succinylcholine and closely monitor the effects of non-depolarising neuromuscular blockade.Reference Medley, Russo and Tobias 200 Anomalies of the kidneys and urinary tract, such as renal aplasia, kidney duplication, horseshoe kidney, and bladder diverticuli, are present in up to 40% of the cases.Reference Pankau, Partsch, Winter, Gosch and Wessel 204 , Reference Sforzini, Milani and Fossali 205 Proteinuria was observed in 25% of patients, suggesting that kidney function should be monitored closely.Reference Ingelfinger and Newburger 206 Although there is predisposition for episodic hypercalcaemia and hypercalciuria, particularly as neonates, nephrocalcinosis is uncommon.Reference Pober, Lacro, Rice, Mandell and Teele 207
Taken together, severe vascular stenosis of the systemic and/or pulmonary arteries increase risk, and asymptomatic patients may be at risk for sudden cardiac death in the setting of occult coronary artery stenosis. These risks pertain to cardiac and non-cardiac procedures.
Noonan syndrome and related disorders
Noonan syndrome has a prevalence of one in 1000–2500 live births.Reference Roberts, Allanson, Tartaglia and Gelb 208 Disease-causing mutations in genes associated with the RAS-MAPK signaling pathway, such as PTPN11 (most frequent), SOS1, RAF1, KRAS, NRAS, BRAF, SHOC2, and CBL, are identified in up to 60% of the cases.Reference Romano, Allanson and Dahlgren 209 Cardiofaciocutaneous syndrome (BRAF, KRAS) and Costello syndrome (HRAS) are disorders related to Noonan syndrome with overlapping phenotypic features and genetic aetiologies.Reference Roberts, Allanson and Jadico 210 Neonatal features of Noonan syndrome include tall forehead, hypertelorism, arched eyebrows, low-set posteriorly rotated ears with thick helices, low posterior hairline, and excessive nuchal skin.Reference Romano, Allanson and Dahlgren 209 Many of these features become more subtle over time, but short stature, pectus deformity, and neck webbing often remain prominent.Reference Roberts, Allanson, Tartaglia and Gelb 208 Patients with Noonan syndrome often achieve normal intelligence,Reference Cesarini, Alfieri and Pantaleoni 211 whereas cardiofaciocutaneous and Costello syndromes often have more significant developmental delay.Reference Roberts, Allanson and Jadico 210 , Reference Axelrad, Glidden, Nicholson and Gripp 212
At least 80% of patients with Noonan syndrome have cardiac lesions including pulmonary valve stenosis (50–60%) and secundum atrial septal defect (6–30%).Reference Roberts, Allanson, Tartaglia and Gelb 208 , Reference Prendiville, Gauvreau and Tworog-Dube 213 Hypertrophic cardiomyopathy is present in ~20% of patients, especially RAF1 mutations, and portends worse survival than non-syndromic hypertrophic cardiomyopathy;Reference Hickey, Mehta and Elmi 214 , Reference Pandit, Sarkozy and Pennacchio 215 however, spontaneous regression occurred in nearly 20% of patients diagnosed in infancy.Reference Prendiville, Gauvreau and Tworog-Dube 213 Fibromuscular dysplasia with clinically significant narrowing of the coronary arteries has been reported in the setting of Noonan syndrome and hypertrophic cardiomyopathy.Reference Ishikawa, Sekiguchi and Akasaka 216 Electrocardiographic abnormalities are frequently observed, including predominantly negative forces in the left pre-cordial leads, left axis deviation, and abnormal Q waves.Reference Croonen, van der Burgt, Kapusta and Draaisma 217 Although there are no particular rhythm abnormalities associated with Noonan syndrome, individuals with Costello syndrome (HRAS mutation) develop atrial tachycardia (often multi-focal) in ~50% of cases.Reference Lin, Alexander and Colan 218 Early post-operative mortality outcomes have not been frequently reported in Noonan syndrome. Cardiac transplantation in the setting of Noonan syndrome is described, but outcome data are similarly scant.Reference Shaw, Kalidas, Crosby, Jeffery and Patton 219 Longitudinal screening for occult hypertrophic cardiomyopathy may be indicated, particularly among those with PTPN11 or RAF1 mutations, in part to mitigate risk during cardiac and non-cardiac procedures.
Systemic features most likely to impact peri-operative outcomes are haematological and lymphatic abnormalities. Haematological abnormalities such as platelet dysfunction and coagulation factor deficiency are present in 30–65% of cases.Reference Romano, Allanson and Dahlgren 209 , Reference Witt, McGillivray and Allanson 220 – Reference Wiegand, Hofbeck, Zenker, Budde and Rauch 223 Severe congenital thrombocytopaenia has been described.Reference Nunes, Aguilar and Prado 224 A recent study reported frequent easy bruising and post-surgical bleeding (15–25%), platelet dysfunction (80%), and factor VII deficiency (20%).Reference Artoni, Selicorni and Passamonti 225 Bleeding diathesis may predispose patients to spontaneous gastrointestinal or sub-arachnoid haemorrhage, which may respond to administration of recombinant factor VII.Reference Tofil, Winkler, Watts and Noonan 226 , Reference Dineen and Lenthall 227 Owing to the risk of coagulopathy, complete blood count and basic coagulation testing is warranted before operations, haematology consultation should be considered, and aspirin may be avoided.Reference Roberts, Allanson, Tartaglia and Gelb 208 , Reference Romano, Allanson and Dahlgren 209
Lymphatic abnormalities are observed in ~20% of cases.Reference Romano, Allanson and Dahlgren 209 Peripheral lymphoedema often spontaneously resolves within the first several years but can have late onset.Reference Ho, Wang and Li 228 Similar to Turner syndrome, pulmonary lymphatic abnormalities including congenital pulmonary lymphangiectasia may predispose to chylothorax.Reference Bellini, Boccardo, Campisi and Bonioli 169 , Reference Fabretto, Kutsche and Harmsen 229 – Reference Goens, Campbell and Wiggins 231 Post-operative pericardial and pleural effusions were not significantly increased in a series of ~120 operations.Reference Prendiville, Gauvreau and Tworog-Dube 213 Cutaneous leaking of lymphatic fluid from a femoral vascular access site due to lymphangiectasia has been reported during cardiac catheterisation.Reference Tsang, Cheung, Leung and Chau 232
Taken together, Noonan syndrome and related disorders are notable for genotype–phenotype relationships such as the associations between RAF1 and hypertrophic cardiomyopathy and HRAS and atrial tachycardia. Bleeding and lymphatic abnormalities may complicate the peri-operative course. Additional peri-operative outcome studies are warranted.
Marfan syndrome and related disorders
Marfan syndrome is present in approximately one in 5000 live births and most commonly caused by mutations in the FBN1 gene, which encodes the extracellular matrix protein fibrillin-1.Reference Dietz, Loeys, Carta and Ramirez 233 Skeletal abnormalities – for example, pectus deformity, long arms, short upper body segment, craniofacial dysmorphism, and arachnodactyly – and ocular abnormalities – such as ectopia lentis and myopia – are often present.Reference Loeys, Dietz and Braverman 234 Cardiovascular involvement consists of aortopathy, characterised by thoracic aortic aneurysm and risk for dissection, and mitral valve prolapse. Development and intellectual ability are typically normal. Although most patients with Marfan syndrome do not require cardiac surgery until adulthood,Reference Gott, Greene and Alejo 235 excellent operative survival has been demonstrated in children undergoing aortic root replacement.Reference Cattaneo, Bethea and Alejo 236 – Reference Roubertie, Ben Ali and Raisky 238 Peri-operative providers should recognise risk for pneumothorax and other pulmonary co-morbidities including pulmonary emphysema.Reference Wood, Bellamy, Child and Citron 239 Pectus deformity or severe scoliosis may also impact surgical approach and recovery. Some patients with particularly severe cardiovascular disease are referred to as having neonatal Marfan syndrome, which is associated with mutations in exons 24–32 of FBN1.Reference Booms, Cisler and Mathews 240 , Reference Sutherell, Zarate and Tinkle 241 Arachnodactyly, congenital contractures, and crumpled ears feature prominently in these neonates, who often present with severe mitral and tricuspid valve regurgitation, leading to cardiac failure and death within the first few months of life. Rare cases of surgical success including quadrivalvar replacement and cardiac transplantation have been reported.Reference Strigl, Quagebeur and Gersony 242 , Reference Krasemann, Kotthoff and Kehl 243
Loeys–Dietz syndrome, which is associated with mutations in the TGF-β receptor genes TGFBR1 and TGFBR2, has overlapping but distinct phenotypic features with Marfan syndrome.Reference Drera, Ritelli and Zoppi 244 Systemic features include hypertelorism, bifid uvula, cleft palate, craniosynostosis, and velvety/thin skin. Talipes equinovarus and camptodactyly may also be diagnostic clues in a neonate.Reference Muramatsu, Kosho and Magota 245 The major cardiovascular manifestations are generalised arterial tortuosity and risk for aneurysm and dissection. Additional cardiovascular lesions include bicuspid aortic valve, atrial septal defect, and mitral valve prolapse. Vascular disease in Loeys–Dietz syndrome is typically more severe than Marfan syndrome with risk of rapid progression and aortic dissection. Dissection is described as early as 6 months of age.Reference Williams, Loeys and Nwakanma 246 There is also often more extensive arterial involvement, which may require complete aortic replacement. Tortuosity and aneurysm of the brachiocephalic and intra-cranial arteries may predispose to cerebrovascular events.Reference Maccarrick, Black and Bowdin 247 , Reference Malhotra and Westesson 248 Despite the aggressive vascular features of the disease, successful aortic root replacement in infancy has been reported.Reference Cleuziou, Eichinger, Schreiber and Lange 249 Furthermore, there were no operative deaths among two series of children with Loeys–Dietz syndrome undergoing aortic root replacement.Reference Williams, Loeys and Nwakanma 246 , Reference Patel, Arnaoutakis and George 250 Cardiovascular complications in the setting of complex CHD have included progressive pulmonary artery dilation and rupture and post-operative mitral leaflet rupture.Reference Muramatsu, Kosho and Magota 245 , Reference Kawazu, Inamura, Kayatani, Okamoto and Morisaki 251 , Reference Nishida, Tamura and Yamazaki 252 Similar to Marfan syndrome, patients with Loeys–Dietz syndrome have increased risk of post-operative pneumothorax.Reference Maccarrick, Black and Bowdin 247 , Reference Patel, Arnaoutakis and George 250 Careful peri-operative positioning should be utilised due to risk of low bone mineral density and increased fracture risk as well as cervical spine anomalies.Reference Maccarrick, Black and Bowdin 247 , Reference Kirmani, Tebben and Lteif 253 – Reference Fuhrhop, McElroy, Dietz, MacCarrick and Sponseller 255 Tortuosity or aneurysm of the peripheral arteries also may impact vascular access.Reference Maccarrick, Black and Bowdin 247
Taken together, early post-operative outcomes are generally favourable for these conditions, but the risk of recurrent aneurysm or dissection mandates lifelong surveillance. Loeys–Dietz syndrome has unusual characteristics that may not be well recognised due to the more recent discovery and characterisation of the disorder.
Alagille syndrome
Alagille syndrome has a prevalence of at least one in 70,000 live births and is associated with the Notch signaling pathway genes JAG1 (97% of cases) and NOTCH2 (1% of cases).Reference Turnpenny and Ellard 256 The hallmark systemic manifestations include bile duct paucity, resulting in cholestasis, facial dysmorphism – deep-set eyes, prominent ears, triangular face with broad forehead, and pointed chin – vertebral anomalies, and ocular anomalies, often posterior embryotoxon. CHD is present in at least 90% of the cases. The most common cardiovascular findings are right-sided lesions including proximal branch pulmonary artery stenosis, peripheral pulmonary artery stenosis, tetralogy of Fallot, or pulmonary valve stenosis. Left-sided lesions and septal defects are also observed but are less frequent.Reference McElhinney, Krantz and Bason 257 In addition to the hallmark systemic features, renal anomalies are observed in ~40% of patients, which includes 20% with renal dysplasia and 5% risk of developing chronic renal failure.Reference Kamath, Podkameni and Hutchinson 258 There is evidence that patients with Alagille syndrome have relatively poor longitudinal outcomes in the setting of tetralogy of Fallot or pulmonary atresia with ventricular septal defect;Reference McElhinney, Krantz and Bason 257 , Reference Blue, Mah and Cole 259 however, positive early outcomes were recently reported among 15 patients with pulmonary atresia and major aortopulmonary collateral arteriesReference Mainwaring, Sheikh, Punn, Reddy and Hanley 260 and six patients undergoing primary surgical reconstruction of peripheral pulmonary artery stenosis.Reference Monge, Mainwaring and Sheikh 181 Owing to congenital biliary anomalies, Alagille syndrome may present the unusual challenge of requiring paediatric cardiac surgery in patients with severe liver disease; two small case series have reported operative mortality in two out of four children with Alagille syndrome and end-stage liver disease undergoing cardiac surgery.Reference Bacha, Hardin and Cronin 261 , Reference Odim, Wu, Laks, Banerji and Drant 262
It is increasingly clear that Alagille syndrome is a disorder characterised by diffuse arteriopathy and that arterial anomalies – aneurysm or stenosis – significantly contribute to poor outcomes. In a large cohort of 268 patients with Alagille syndrome, systemic arterial anomalies or intra-cranial vascular events were present in nearly 10% of patients, and vascular accidents were responsible for 34% of the observed mortality.Reference Kamath, Spinner and Emerick 263 Spontaneous haemorrhage in the gastrointestinal tract, nasal/oral mucosa, and uterine lining are also reported in the absence of liver failure. It is speculated that elevated levels of apolipoprotein E may impair normal haemostasis,Reference Lykavieris, Crosnier, Trichet, Meunier-Rotival and Hadchouel 264 but a primary arterial fragility may be likely. A unique case report of a child with recurrent aortopulmonary shunt dehiscence due to extensive atherosclerosis and plaque at the anastomosis site has prompted some to consider routine screening and treatment for dyslipidaemia to prevent exacerbation of arterial disease in these patients.Reference May, Hanley, Connolly and Reddy 265 Taken together, systemic arteriopathy presents significant challenges to both early and late survival outcomes.
Trisomy 13 and 18
Patients with trisomy 13 – Patau syndrome – or trisomy 18 – Edwards syndrome – have severe co-morbidities and poor prognosis with >90% of the affected infants dying by age 1 year. Given the severe multi-systemic nature of these disorders, the presence of CHD may not impact overall survival.Reference Rasmussen, Wong, Yang, May and Friedman 266 Cardiac lesions are most commonly septal defects, but left ventricular non-compaction associated with progressive heart failure has been described in trisomy 13.Reference McMahon, Chang and Pignatelli 267 , Reference Yukifumi, Hirohiko, Fukiko and Mariko 268 Despite poor overall survival, cardiac operations including palliative and complete repairs may be beneficial in select groups.Reference Maeda, Yamagishi and Furutani 269 , Reference Graham, Bradley, Shirali, Hills and Atz 270 The care for these patients and families requires a balanced multi-disciplinary approach including palliative care specialists.
CHARGE syndrome
CHARGE syndrome is present in approximately one in 8500 live births.Reference Issekutz, Graham, Prasad, Smith and Blake 271 Most cases (~70%) are associated with mutation in the CHD7 gene, which encodes a chromodomain helicase DNA-binding protein, and are rarely associated with mutation in SEMA3E;Reference Zentner, Layman, Martin and Scacheri 272 , Reference Lalani, Safiullah and Molinari 273 22q11 deletion has also been described in patients clinically diagnosed with CHARGE syndrome.Reference Corsten-Janssen, Saitta and Hoefsloot 274 The major diagnostic criteria (“four C’s”) are coloboma, choanal atresia, cranial nerve dysfunction, and characteristic ear anomalies, external and middle ear anomalies.Reference Blake and Prasad 275 CHD is present in ~75% of patients and includes conotruncal and septal defects, including atrioventricular septal defects.Reference Zentner, Layman, Martin and Scacheri 272 , Reference Corsten-Janssen, Kerstjens-Frederikse and du Marchie Sarvaas 276 Forebrain central nervous system malformations are frequently observed,Reference Lin, Siebert and Graham 277 yet significant intellectual disability is not guaranteed.Reference Blake and Prasad 275 Immunological dysfunction including severe T-cell deficiency has been reported.Reference Jyonouchi, McDonald-McGinn, Bale, Zackai and Sullivan 278 Renal anomalies are observed in ~30–40% cases and include solitary kidney, hydronephrosis, renal hypoplasia, duplex kidneys, and vesicoureteral reflux.Reference Blake and Prasad 275
Peri-operative outcomes have not been frequently reported, but sub-optimal longitudinal outcomes for patients with conotruncal defects have been suggested.Reference Michielon, Marino and Oricchio 31 A major peri-operative risk factor is the high frequency of anatomical and functional abnormalities of the respiratory tract. Upper airway anomalies – choanal atresia, cleft lip/palate, and micrognathia – and laryngotracheal anomalies – tracheoesophageal fistula, laryngomalacia, tracheomalacia, sub-glottic stenosis, laryngeal cleft, and anterior larynx – may complicate airway management.Reference Stack and Wyse 279 , Reference Morgan, Bailey and Phelps 280 Cranial nerve dysfunction – for example, cranial nerves IX and X – leads to pharyngeal and laryngeal dysfunction and poor airway protection, a problem that may be exacerbated by high frequency of gastroesophageal reflux.Reference Bergman, Blake and Bakker 281 Indeed, post-operative airway events are frequently encountered – 35% in a recent series – occurring most frequently after cardiac surgery.Reference Blake, MacCuspie and Hartshorne 282 In an early case series, over half of deaths were attributed to pulmonary aspiration.Reference Blake, Russell-Eggitt, Morgan, Ratcliffe and Wyse 283 , Reference Wyse, Al-Mahdawi, Burn and Blake 284 Pituitary structural abnormalities may be associated with neonatal hypocortisolism and should be considered in cases of refractory hypotension.Reference James, Aftimos and Hofman 285 , Reference Gregory, Gevers and Baker 286
Rare genetic syndromes associated with CHD have features predisposing to poor peri-operative outcomes that may be sub-optimally recognised by providers due to lack of familiarity
Ellis–van Creveld syndrome
Ellis–van Creveld syndrome is a rare autosomal-recessive disorder (EVC or EVC2 mutations) with increased occurrence among the Amish population inhabiting Pennsylvania, United States of America.Reference Baujat and Le Merrer 287 Frequent characteristics include short stature, polydactyly, short ribs, and dysplastic nails, hair, and teeth. Notably, cognitive development is normal. CHD is present in ~60% and includes common atrium, atrioventricular septal defect, and systemic and pulmonary venous abnormalities.Reference O’Connor, Rider and Thomas Collins 288 , Reference Hills, Kochilas, Schimmenti and Moller 289 Overall, three noteworthy retrospective studies have analysed cardiac surgical outcomes. A case series of nine patients undergoing cardiac surgery at a single centre from 2004 to 2009 observed a preponderance of respiratory morbidity.Reference O’Connor, Rider and Thomas Collins 288 Death occurred within 150 days after surgery in four out of nine patients, primarily due to respiratory failure. Respiratory complications, including three of five survivors requiring tracheostomy, were attributed to a thoracic dystrophy similar to Jeune syndrome. Increased procedure-related respiratory morbidity was also observed in the Pediatric Health Information System database from 2004 to 2011.Reference O’Connor, Tang and Collins 290 In fairly stark contrast with these reports, a review of the Pediatric Cardiac Care Consortium database from 1982 to 2007 identified no operative mortality among 21 children undergoing cardiac surgery.Reference Hills, Kochilas, Schimmenti and Moller 289 The reason for the discrepancy between these reports is unclear. Notably, thoracic dystrophy may improve with somatic growth, suggesting benefit of deferring surgery for as long as possible.Reference O’Connor, Rider and Thomas Collins 288 Together, these observations indicate the need for complete pulmonary evaluation and consideration of invasive haemodynamic assessment before cardiac operations.
VACTERL
VACTERL association likely represents a genetically heterogeneous population consisting of vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula with oesophageal atresia, renal anomalies, and limb defects.Reference Solomon 291 The renal anomalies include unilateral agenesis, horseshoe kidney, cystic disease, and dysplasia, and there is risk for chronic kidney disease with progression to end-stage renal disease.Reference Ahn, Mendoza, Kaplan and Reznik 292 In a cohort of 46 patients, 31 had CHD, which was most frequently ventricular septal defect.Reference Cunningham, Hadley and Hannoush 293 Probably due to the currently imprecise nature of this diagnosis, there are little outcomes data available.
PHACES
PHACES association includes posterior fossa malformations, haemangioma – often large, segmental, and involving the head or neck – arterial anomalies, cardiac defects, eye abnormalities, and sternal defects.Reference Rao, Drolet, Holland and Frommelt 294 A genetic aetiology has not been established. Arterial manifestations include anomalous patterning, stenosis, occlusion, or aneurysm of the cervical and/or cerebral arteries, which are usually ipsilateral to the haemangioma.Reference Hess, Fullerton and Metry 295 , Reference Heyer, Dowling and Licht 296 Aortic arch sidedness is also often ipsilateral to the haemangioma.Reference Bronzetti, Giardini and Patrizi 297 Cardiovascular malformations are present in ~40% of patients, including aberrant subclavian artery, coarctation of the aorta (~20%), and ventricular septal defect (~15%).Reference Bayer, Frommelt and Blei 298 Coarctation morphology is often complex and is rarely associated with bicuspid aortic valve.Reference Rao, Drolet, Holland and Frommelt 294 Preparation for surgical repair of coarctation should include a complete evaluation of the aortic arch and head and neck arteries by cardiac catheterisation or other imaging modality to optimise surgical approach.Reference Rao, Drolet, Holland and Frommelt 294 , Reference Giardini, Gholam, Khambadkone and Kostolny 299 Peri-operative providers should also recognise increased risk for sub-glottic haemangioma and risk for ischaemic stroke and seizures during infancy.Reference Hartemink, Chiu, Drolet and Kerschner 300 – Reference Burrows, Robertson and Mulliken 302
Cri du chat syndrome
Cri du chat syndrome (5p15 deletion) has a prevalence of approximately one in 15,000 live births.Reference Cerruti Mainardi 303 A distinguishing feature is the characteristic high-pitched cry. Neonatal craniofacial features include microcephaly and round face with large nasal bridge, hypertelorism, and micrognathia. Severe psychomotor and growth delay is observed in most cases. Tracheal intubation may be complicated by the presence of laryngeal abnormalities including small larynx, narrow diamond-shaped larynx, and laryngomalacia, and large, floppy epiglottis.Reference Yamashita, Tanioka, Taniguchi, Matsuki and Oyama 304 CHD is present in ~20% of the patients, including patent ductus arteriosus, ventricular septal defect, atrial septal defect, and right ventricular outflow tract obstructive lesions including tetralogy of Fallot.Reference Hills, Moller, Finkelstein, Lohr and Schimmenti 305 Outcomes data are limited, but a review of the Pediatric Cardiac Care Consortium from 1982 to 2002 identified 18 children undergoing cardiac surgery, including five complete tetralogy of Fallot repairs, who had good overall survival with one operative death.Reference Hills, Moller, Finkelstein, Lohr and Schimmenti 305
Jacobsen syndrome
Jacobsen syndrome has a prevalence of approximately one in 100,000 live births and is associated with a deletion on the long arm of chromosome 11 with break point at 11q23.Reference Grossfeld, Mattina and Lai 306 The pathogenic gene for cardiovascular manifestations may be ETS1.Reference Glessner, Bick and Ito 16 Dysmorphic features include skull deformity – for example, trigonocephaly – hypertelorism, strabismus, low posteriorly rotated ears, and syndactyly. Intellectual disability and behavioural abnormalities are observed in the majority of cases. CHD occurs in ~50% of cases, primarily consisting of ventricular septal defect or left-sided obstructive lesion, including up to 5% with hypoplastic left heart syndrome.Reference Mattina, Perrotta and Grossfeld 307 , Reference Favier, Jondeau and Boutard 308 Importantly, there is often increased bleeding risk due to a platelet disorder – Paris–Trousseau syndrome – characterised by neonatal thrombocytopaenia, which can be severe but improves with age, and platelet dysfunction, which often persists.Reference Grossfeld, Mattina and Lai 306 , Reference Favier, Jondeau and Boutard 308 Pre-operative evaluation of platelet function using thromboelastography may be warranted. Airway management can be complicated by micrognathia and anterior laryngeal opening.Reference Blaine Easley, Sanders, McElrath-Schwartz, Martin and Mark Redmond 309 Central hypothyroidism has been reported.Reference Pivnick, Velagaleti and Wilroy 310 Renal and urinary tract malformations, including dysplasia, hydronephrosis, and unilateral agenesis, occur rarely.Reference Grossfeld, Mattina and Lai 306 , Reference Mattina, Perrotta and Grossfeld 307
Kabuki syndrome
Kabuki syndrome has a prevalence of approximately one in 32,000 live births and in most cases is associated with mutations in the MLL2 gene, which encodes a histone methyltransferase.Reference Ng, Bigham and Buckingham 311 , Reference Niikawa, Kuroki and Kajii 312 Its naming is derived from a characteristic appearance of long palpebral fissures with lower eyelid eversion and arched eyebrows, resembling masks worn in Kabuki theatre. Another characteristic finding is foetal finger pads. Intellectual disability is present in ~90% and seizures in 12–25%.Reference Schrander-Stumpel, Spruyt, Curfs, Defloor and Schrander 313 – Reference Bogershausen and Wollnik 315 Cardiac defects are present in ~50% of cases and include ventricular septal defect, atrial septal defect, left-sided obstructive lesions – most commonly coarctation of the aorta – and tetralogy of Fallot.Reference Schrander-Stumpel, Spruyt, Curfs, Defloor and Schrander 313 , Reference Digilio, Marino, Toscano, Giannotti and Dallapiccola 314 , Reference Armstrong, Abd El Moneim and Aleck 316 Abnormalities in humoral immunity, including low levels of IgA, total IgG, or IgG sub-classes, were observed in ~50%, which may explain the predisposition to upper respiratory infections, and potentially impacts peri-operative risk.Reference Hoffman, Ciprero and Sullivan 317 Cleft lip/palate including sub-mucous clefts occurs in ~50%.Reference Schrander-Stumpel, Spruyt, Curfs, Defloor and Schrander 313 Renal abnormalities include renal dysplasia, agenesis, horseshoe kidney, ectopic kidney, and hydronephrosis.Reference Armstrong, Abd El Moneim and Aleck 316
Smith–Magenis syndrome
Smith–Magenis syndrome has a prevalence of approximately one in 25,000 live birthsReference Greenberg, Guzzetta and Montes de Oca-Luna 318 and is associated with the deletion of 17p11.2.Reference Greenberg, Guzzetta and Montes de Oca-Luna 318 , Reference Elsea and Girirajan 319 Craniofacial features include broad face with hypertelorism and upslanting eyes, prognathism, low-set ears, cleft lip/palate, and ocular abnormalities.Reference Edelman, Girirajan and Finucane 320 Mild-to-moderate developmental delay is often observed along with characteristic neurobehavioural features such as sleep disturbance with inverted circadian rhythm and predilection for self-injury.Reference Edelman, Girirajan and Finucane 320 CHD is present in ~30–40% and includes ventricular septal defect, atrial septal defect, right-sided lesions including tetralogy of Fallot, and total anomalous pulmonary venous return.Reference Edelman, Girirajan and Finucane 320 – Reference Myers and Challman 322 The cardiovascular risk profile includes predisposition for dyslipidaemia, including hypercholesterolaemia.Reference Smith, Gropman and Bailey-Wilson 323 Post-operative ischaemic stroke in a young adult with premature cerebrovascular atherosclerosis has been reported.Reference Chaudhry, Schwartz and Singh 324 Immunoglobulin levels are low in ~20%.Reference Greenberg, Lewis and Potocki 321 Hypothyroidism presents in ~30%.Reference Greenberg, Lewis and Potocki 321 Epileptiform abnormalities are present in ~50%, and clinical seizures develop in ~20–30%.Reference Edelman, Girirajan and Finucane 320 , Reference Goldman, Potocki and Walz 325 Renal and urinary tract anomalies are present in ~15% and include renal dysplasia, small kidney, vesicoureteral reflux, renal agenesis, and ureteral duplication.Reference Edelman, Girirajan and Finucane 320 , Reference Myers, Challman and Bock 326
Wolf–Hirschhorn syndrome
Wolf–Hirschhorn syndrome has a prevalence of approximately one in 20,000 live births and is associated with the deletion of 4p16.3.Reference Maas, Van Buggenhout and Hannes 327 , Reference Battaglia, Filippi and Carey 328 Patients characteristically have the appearance of a “Greek warrior helmet” with high forehead, prominent glabella, and protruding eyes with hypertelorism.Reference Battaglia, Filippi and Carey 328 Micrognathia, forehead haemangioma, and cleft lip/palate also occur with increased frequency. Severe developmental delay is uniformly observed, and seizures occur in ~90% of individuals starting at a young age.Reference Battaglia, Filippi, South and Carey 329 CHD is present in ~50%, most commonly atrial septal defect, pulmonary stenosis, ventricular septal defect, and patent ductus arteriosus, but more complex lesions have been reported.Reference Battaglia, Filippi and Carey 328 , Reference von Elten, Sawyer, Lentz-Kapua, Kanis and Studer 330 , Reference Tautz, Veenma and Eussen 331 Defects in humoral immunity, including common variable immunodeficiency and isolated IgA deficiency, are frequently observed.Reference Hanley-Lopez, Estabrooks and Stiehm 332 Renal and urinary tract defects are observed in ~30% and include vesicoureteral reflux, renal agenesis, dysplasia, or hypoplasia, and horseshoe kidney.Reference Battaglia, Filippi and Carey 328
Cornelia de Lange syndrome
Cornelia de Lange syndrome, also known as Brachmann–de Lange syndrome, has a prevalence of approximately one in 10,000 live births and is caused by mutations in the NIPBL, SMC1A, or SMC3 genes, which encode gene products involved in the function of cohesin, a protein complex involved in cell division.Reference Liu and Krantz 333 Patients have consistent craniofacial features including short neck, low posterior hairline, hirsute forehead, arched and confluent eyebrows, and thick and long eyelashes.Reference Jackson, Kline, Barr and Koch 334 Mild-to-moderate intellectual disability is frequent.Reference Kline, Stanley and Belevich 335 CHD is present in ~30% and includes pulmonary valve stenosis, peripheral pulmonary artery stenosis, atrial septal defect, ventricular septal defect, left-sided obstructive lesions, and tetralogy of Fallot; there is also risk for progressive atrioventricular valve dysplasia.Reference Selicorni, Colli and Passarini 336 , Reference Chatfield, Schrier and Li 337
Airway management may be complicated by micrognathia, cleft palate, sub-mucous cleft, short, stiff neck, and restricted mouth opening.Reference August and Sorhabi 338 Recurrent infections including fungal infections are reported at increased frequency, and humoral deficiency and T-cell abnormalities have been observed.Reference Jyonouchi, Orange, Sullivan, Krantz and Deardorff 339 Thrombocytopaenia has been observed in ~20%.Reference Lambert, Jackson and Clark 340 Renal and urinary tract anomalies are observed in ~40% of patients and most frequently renal dysplasia, pelvic dilation, and vesicoureteral reflux are observed.Reference Selicorni, Sforzini and Milani 341 Seizures, often partial type, occur in ~25%.Reference Verrotti, Agostinelli and Prezioso 342
Holt–Oram syndrome
Holt–Oram syndrome, which is characterised by the triad of atrial septal defect, conduction abnormality, and upper limb malformation – most commonly thumb – has a prevalence of approximately one in 100,000 live births and is caused by mutations in the cardiac transcription factor TBX5.Reference Bossert, Walther and Gummert 343 Cardiac lesions include atrial septal defect, which is most common, ventricular septal defect, and more complex lesions such as conotruncal defects, atrioventricular canal defects, and left-sided obstructive lesions.Reference Bossert, Walther and Gummert 343 The most frequent conduction abnormality is atrioventricular block, most commonly first degree, which may be present in the absence of structural CHD.Reference Newbury-Ecob, Leanage, Raeburn and Young 344 Aside from the risk of atrioventricular block or other conduction disturbances, there are typically no other significant co-morbidities expected to complicate peri-operative care.
Goldenhar syndrome
Goldenhar syndrome, also known as oculo-auriculo-vertebral spectrum, occurs in up to one in 6000 live births.Reference Digilio, Calzolari and Capolino 345 Although suspected to be due to abnormal development of the first and second branchial arches, the genetic cause is presently unknown; however, 22q11 deletion was recently reported in patients diagnosed with this disorder.Reference Digilio, McDonald-McGinn and Heike 346 The defining features include unilateral microtia, hemifacial microsomia with mandibular hypoplasia, ocular epibulbar dermoid, and cervical vertebral malformations.Reference Rollnick, Kaye, Nagatoshi, Hauck and Martin 347 CHD is present in ~30% of cases and includes conotruncal defects, ventricular septal defect, and atrial septal defect.Reference Digilio, Calzolari and Capolino 345 Significant craniofacial distortion and cervical vertebral anomalies may complicate airway management.Reference Ozlu, Simsek, Alacakir and Yigitkanli 348 Renal and urinary tract anomalies include ectopic or fused kidneys, renal agenesis, and vesicoureteral reflux.Reference Ritchey, Norbeck, Huang, Keating and Bloom 349
Conclusion
The impact of a genetic syndrome and associated co-morbidities on the peri-operative course and outcomes cannot be understated (Table 3). Recognising the risk factors particular to specific genetic syndromes has the potential to prevent or ameliorate peri-operative complications and improve short-term and long-term outcomes (Table 2 and Supplementary Table S3). The development of peri-operative management protocols tailored to specific syndromes based on current knowledge may be an effective strategy to achieve these goals. Understanding the cause is essential to elucidate pathogenesis and develop new treatment strategies. As the capability to interrogate and comprehend the genetic basis of CHD improves and clinical availability of genetic testing proliferates, there are increasing opportunities for early diagnosis, risk stratification, genetic counselling, and anticipatory clinical care.Reference Lin, Salbert, Belmont and Smoot 350 We propose that these tasks may be most effectively achieved by the establishment of multi-disciplinary sub-specialty cardiovascular genetics services.
Table 3 Key points.
![](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20170718130426-72237-mediumThumb-S1047951115001389_tab3.jpg?pub-status=live)
In order to advance peri-operative management, there are present and future needs to integrate registries containing careful phenotyping and clinical outcomes data – for example, Society of Thoracic Surgeons database and Pediatric Heart Network – with registries containing comprehensive genetic data – for example, the Pediatric Cardiac Genomics Consortium.Reference Jacobs, Jacobs and Franklin 351 , Reference Gelb, Brueckner and Chung 352 There are a limited number of exemplary studies that illustrate the value of performing comprehensive genetic evaluations and specifically reporting not only positive genetic testing results but also negative results to optimise interpretation and generalisability.Reference Michielon, Marino and Oricchio 31 , Reference Anaclerio, Di Ciommo and Michielon 33 This design may be more challenging to implement in large registries but should be considered for establishment and updating of registries as genetic testing advances. As clinical investigators continue to delineate the clinical significance of genetic diagnoses and apply the evidence to peri-operative care, there is promise for improvement in both short-term and long-term outcomes, such as neurodevelopment, quality of life, and general health into adulthood.Reference Marino, Lipkin and Newburger 17 , Reference Marino, Tomlinson and Wernovsky 18 , Reference Lin, Basson and Goldmuntz 353
Acknowledgements
None.
Financial Support
This manuscript received no specific grant from any funding agency, commercial, or not-for-profit sectors.
Conflicts of Interest
None.
Supplementary Material
For supplementary materials referred to in this article, please visit http://dx.doi.org/10.1017/S1047951115001389